Frequency of and Determinants for Psychotropic Drug Use in an Institution for the Mentally Retarded

1990 ◽  
Vol 156 (4) ◽  
pp. 525-530 ◽  
Author(s):  
Olav M. Linaker
Keyword(s):  
Drug Use ◽  
General Population ◽  
Psychotropic Drug ◽  
Small Proportion ◽  
Psychiatric Diagnosis ◽  
Anticonvulsant Drug ◽  
Mentally Retarded ◽  
Significant Trend ◽  
Disruptive Behaviour ◽  
Psychiatric Diagnoses

The frequency of psychotropic and anticonvulsant drug use in 168 institutionalised mentally retarded adults was studied. Use of neuroleptics and anticonvulsants was more frequent and use of hypnotics and antidepressants less frequent than in the general population. Neuroleptics were given to 49% of the population. Clients with no psychiatric diagnosis consumed less neuroleptics than those with such a diagnosis, and there was a non-significant trend for those with a more serious diagnosis (e.g. schizophrenia) to take a higher dosage. The degree of disruptive behaviour and the availability of a physician were related to dosage of neuroleptics. The various psychiatric diagnoses given could explain only a small proportion of the variance in dosage.

Social selection in cohort studies and later representation of childhood psychiatric diagnoses: The Danish National Birth Cohort

2017 ◽  
Vol 48 (2) ◽  
pp. 207-213 ◽  
Author(s):  
Kathrine Bang Madsen ◽  
Lena Hohwü ◽  
Jin Liang Zhu ◽  
Jørn Olsen ◽  
Carsten Obel
Keyword(s):  
General Population ◽  
Birth Cohort ◽  
Psychotropic Medication ◽  
Psychiatric Diagnosis ◽  
Psychiatric Diagnoses ◽  
Social Selection ◽  
Obsessive Compulsive ◽  
Compulsive Disorder ◽  
Danish National Birth Cohort ◽  
Icd 10

Aim: This study aimed to estimate the relative representation of childhood psychiatric diagnoses and use of psychotropic medication in the Danish National Birth Cohort (DNBC) compared to the general population. Methods: The general population was identified as all childbirths in Denmark during 1998–2002 ( N=344,160). Linking the DNBC ( N=91,442) and the general population to the Danish national health registries, all children were followed until they received an ICD-10 psychiatric diagnosis, had a prescription of psychotropic medication or to the end of follow-up in 2013. The prevalence ratios (PRs) with corresponding 95% confidence intervals (CI) were estimated for each psychiatric diagnosis and by sex. Age at first diagnosis presented as means were compared using the one-sample t-test. Results: In the DNBC, the selected childhood psychiatric diagnoses were underrepresented by 3% (PR=0.97, 95% CI 0.94–0.99), ranging from a 20% underrepresentation for schizophrenia (PR=0.80, 95% CI 0.59–1.09) to a 6% over-representation for anxiety disorder or obsessive-compulsive disorder (PR=1.06, 95% CI 0.97–1.17). The majority of the specific diagnoses were modestly underrepresented in the DNBC compared to the general population, while use of psychotropic medication had similar representation. Girls were generally more underrepresented than boys. Depression was on average diagnosed 0.4 years earlier in the DNBC than in the general population ( p=0.023). Conclusions: These findings suggest that the social selection may influence the prevalence of diagnosed childhood psychiatric disorders in the DNBC.

Psychotropic drug use in mentally retarded group home residents with behavioural problems

2000 ◽  
Vol 10 ◽  
pp. 399
Author(s):  
J.J. Stolker ◽  
P.J. Koedoot ◽  
E.R. Heerdink ◽  
H.G.M. Leufkens ◽  
W.A. Nolen
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Group Home ◽  
Mentally Retarded ◽  
Behavioural Problems ◽  
Psychotropic Drug Use

Psychotropic drug use in a sample of general population in the Sardinia region

2003 ◽  
Vol 12 (4) ◽  
pp. 287-292 ◽  
Author(s):  
Mauro Giovanni Carta ◽  
Maria Carolina Hardoy ◽  
Mariangela Cadeddu ◽  
Gioia Mura ◽  
Anna Laura Floris ◽  
...  
Keyword(s):  
European Union ◽  
Drug Use ◽  
General Population ◽  
General Practitioners ◽  
Psychotropic Drug ◽  
The European Union ◽  
Research Support ◽  
Cross Sectional ◽  
Psychotropic Drug Use ◽  
Depressive Episodes

SummaryAims - To present the results of an epidemiologic research about psychotropic drug use inSardinia. Methods - Cross-sectional study on a sample of 1040 subjects randomly selected from registers. Setting - Community survey on three areas of Sardinia region. Evaluation: interviews carried out byphysicians by means of Italian version of the Composite International Diagnostic Interview Simplified.Drug consumption was evaluated concerning last week before the interview. Main Outcome Measures: point prevalence. Results - The rate of adults of the general population that consumed benzodiazepines was 10.1%, antidepressants 4.2%, 14.7% of the sample was using psychotropic drugs. 60% of subjects with diagnosis of ICD-10 Depressive Episod did not have the right pharmacologic treatment. A relevant proportion of subjects without lifetime psychiatric diagnosis (anxiety and/or depression) used antidepressants (0.8%). The pharmacologic therapies were managed by psychiatrics in 44.2% of cases, antidepressants were managed by general practitioners in 31.8% of subjects. Conclusions - The research underlines an increase of meet needs in subjects affected by depressive episodes against a previous Sardinian survey carried out over ten years ago. This change is parallel to a more frequent management of therapies by general practitioners. Their role seems to become more relevant in treating depressive illness.Declaration of InterestMauro Giovanni Carta has received grants and research support from Regione Autonoma della Sardegna, Council of the European Union, European Union DGXII, GlaxoSmithKline, Pfizer, Lundbeck, Pharmacia, Recordati. Maria Carolina Hardoy has received grants and research support from University of Pisa, GlaxoSmithKline, Pfizer, Farmades. Bernardo Carpiniello has received grants and research support from GlaxoSmithKline, Pfizer, Recordati, Janssen Cilag, EliLilly, Astra Zeneca.

Sign in / Sign up

Export Citation Format

Share Document